 1. Patient has known hypersensitivity or contraindication to aspirin, both heparin and bivalirudin, antiplatelet medication specified for use in the study clopidogrel, prasugrel, and ticagrelor, sirolimus or its derivatives, poly L-lactide, poly D,L-lactide, platinum-iridium, or contrast sensitivity that cannot be adequately pre-medicated. 